Biovation Launches Bioarmour™ Blood Pressure Cuff Shield

FOR RELEASE: IMMEDIATE

Biovation Launches Bioarmour™ Blood Pressure Cuff Shield, An Infectious Disease Barrier Product For Hospitals And Healthcare Facilities

Blood pressure cuff shield from Biovation offers an antimicrobial hygienic barrier against hospital acquired infections; medical product is now available to European and Canadian markets

blood-pressure-cuff-shield Biovation has launched the BioArmour Blood Pressure Cuff Shield (BPCS) to mitigate the spread of infectious pathogens from blood pressure cuffs.  This first-in-class medical product offers a multi-use barrier for prevention of hospital acquired infections (HAIs). The BPCS has been designed, tested and validated over a two-year cycle, and is now available in European, Canadian and all non-US markets. BioArmour is the first in a suite of infection and pathogen control products from Biovation.

Biovation is a technology design and manufacturing company that produces advanced, non-woven fiber products with integrated antimicrobial properties for packaging, healthcare, specialty niche roll goods and wipes products and other specialty advanced material end products. BioArmour was developed and tested in close collaboration with a large hospital system to proactively provide solutions for the mitigation of HAIs.

The easy-to-use BioArmour BPCS is a disposable antimicrobial hygienic barrier that attaches to the blood pressure cuff to prevent direct contact of the cuff with the patient’s skin. The latex-free shield material is composed of a sustainable biopolymer impregnated with antimicrobial and antifungal agents to mitigate the propagation of a wide spectrum of pathogens in controlled release fashion. Contaminant pathogens – including MRSA, VRE, c. difficile and others – are mitigated by the blood pressure cuff shield, allowing for multi-patient use over a 24-hour period.

In lab testing, the BioArmour BPCS has been shown to kill up to 99.99% of tested microorganisms.  The BPCS is manufactured with green technology and a sustainable biopolymer, with an industry-leading 74% biocontent.  Its slim profile does not adversely impact accuracy of the blood pressure measurement data.  And, the BPCS provides another tool for risk mitigation for hospitals and healthcare facilities with proactive measures for infectious disease reduction and control.  This cost-effective system requires no staff maintenance or disinfection between patients and is targeted for in-patient, physician offices, hospice and nursing home facilities and emergency medical services.

“Our BioArmour Blood Pressure Cuff Shield is a proactive measure that helps hospitals and healthcare facilities support their infectious disease reduction and control efforts,” says Biovation Chief Executive Officer Kerem Durdag. “It is an easy-to-use and cost-effective tool that contributes to patient health and safety. The proprietary manufacturing technology we have employed sets a benchmark for our products in our pipeline.”

Sciessent partnered with Biovation to develop the antimicrobial technology. “The BioArmour Blood Pressure Cuff Shield infuses our world-class antimicrobial solutions into Biovation’s biopolymer fibers to result in a safe, non-leaching product with broad-spectrum efficacy,” says Lise Moloney, Director of Business Development – Healthcare, Sciessent. “We’re proud to have partnered with Biovation to bring this industry-leading product to market.”

The BioArmour BPCS has been registered a CE Class I medical device marked for distribution in the EU.  As a medical product, it is available for sale in Canada and all other non-US countries.  It is currently undergoing testing for US FDA approval, which is anticipated to be received in late summer 2015.

About Sciessent, LLC

Sciessent is a leading provider of customized antimicrobial solutions that enhance the value of customers’ products. Agion antimicrobial solutions from Sciessent have been incorporated into a wide range of healthcare, industrial and consumer applications, including medical devices such as central-venous catheters and IV access ports, drinking-water applications like water filters and ice-making equipment, and textiles and apparel. The company’s brands include Agion, Agion Active and Sciessent Lava and are based on naturally occurring elements. Sciessent customers include leading international brands including Vygon, Medegen, Scotsman, Everpure, Follett, Honeywell, UnderArmour, Adidas, Reebok and Skechers.

About Biovation II, LLC

Biovation is a technology design and manufacturing company that manufactures advanced non-woven fiber products with integrated antimicrobial properties for packaging, healthcare, custom advanced material OEM products, and other specialty scalable applications. Biovation has extensive experience with green and sustainable biopolymers such as polylactic acid, which comes from cornstarch. It is a portfolio company of Anania & Associates Investment Company (www.anania.biz), a Maine-based private equity fund that invests in small, well-managed businesses. For more information, call +1.207.633.0616 or visit www.biovation.com.

CONTACT: Keri Seitz: kseitz@biovation.com ; +1.207.633.0616 x 27

Ray Walsh Joins Biovation As Director of Operations

FOR RELEASE: IMMEDIATE

Walsh will lead Biovation’s operations groups as it prepares for ISO 13485 certification and to implement new equipment and processes

BOOTHBAY, ME – Biovation, a manufacturer of biopolymer non-woven fiber products for medical, packaging, and specialty markets, announces that Ray Walsh has joined the executive management team as Director of Operations. Walsh brings significant experience in manufacturing to his new post, where he is responsible for growing and managing the operations department, and providing leadership for Biovation’s facilities, process and manufacturing personnel.

Walsh previously served as Director – Project Manager for Biovation’s parent company, Anania & Associates. His background includes positions in diversified process industries, including pulp/paper and converting, real-time online instrumentation and process control, seafood, building products, and industrial microwave equipment manufacturing. He has served in numerous roles, including in engineering, sales, marketing, and operations. Walsh also has experience managing large crews, including a manufacturing facility and for a seafood processing/sales company .

“I am very pleased that Ray has joined our team and will lead our operations efforts as we implement our growth strategies. During the last several years we have successfully installed a unique and differentiated biopolymer non-woven manufacturing line and are now poised to leverage its continuous operation to customer specific products,” says Biovation Chief Executive Officer Kerem Durdag. ”Ray’s years of experience with and knowledge from global manufacturing companies will be beneficial to our operations in 2015 and beyond.”

Biovation will release several new products within this calendar year, including an infection control barrier product (the BioArmour™ Blood Pressure Cuff Shield), a specialty advanced product for the Department of Defense (the DryRight™), and several roll goods products for niche markets. Additionally, with the implementation of the ISO 13485 processes and systems, new manufacturing equipment is being installed to ensure high-throughput product delivery for Biovation’s growing customer base.

About Anania & Associates Investment Company LLC

Anania & Associates Investment Company LLC (AAI) is a Maine based and focused private equity firm that partners with management teams acquiring and building companies with a high potential for growth. Founded in 2008 the fund currently has 8 portfolio companies representing over 450 employees and $75 million in revenue.  AAI is a long term, regionally focused investor focused on supporting sustainable growth for its portfolio companies which include: Biovation II LLC, Elmet Technologies LLCGrow-Tech LLCLighthouse Imaging LLCMEGA Industries LLCmWAVE Industries LLCSynergistic Software Solutions LLC & TrakTec LLC.

About Biovation II, LLC

Biovation is a technology design and manufacturing company that manufactures advanced polylactic acid (PLA)-based non-woven fiber end products and roll goods with integrated antimicrobial properties for packaging, infection control, advanced wound care, hygiene, and other specialty applications. Biovation has extensive experience with green biopolymers such as,PLA, which comes from cornstarch and is completely biodegradable. For more information, call +1.207.633.0616 or visit www.biovation.com. CONTACT: Kerem Durdag: kdurdag@biovation.com; 207.632.2559

Innovative Boot-Drying Technology Undergoes Successful Test by U.S. Marine Corps

FOR RELEASE: IMMEDIATE

Biovation’s biodegradable, bioplastics DryRight product benchmarked to prepare for high-volume domestic manufacturing and delivery in 2015 

After months of testing, the Biovation DryRight tactical boot drying product has received positive feedback from the United States Marine Corps. The testing resulted from a Broad Agency Announcement Contract received by Biovation in June 2013. These strong results will lead to the finalization of product design and the commercialization of the DryRight product in 2015 concurrently with the completion of a final field trial by the United States Marine Corps. The development of this innovative product would not have been achieved without the support of Marine Corps System Command in Quantico, Virginia.

Biovation is a technology design and manufacturing company that produces advanced, non-woven fiber products with integrated anti-microbial properties for packaging, healthcare, custom advanced material OEM products, and other specialty scalable applications. The DryRight product was funded, developed, and tested in close collaboration with the United States Marine Corps to help them perform at their best.

This easy-to-use solution is rolled and inserted into a wet boot. Over time, the anti-microbial materials dry the boot and ensure the foot health of the wearer. Poor foot care is a significant contributor to lost combat readiness. DryRight is lightweight, portable, and prevents unnecessary foot injury while never needing to be wrung out or washed, making it a necessary tool for today’s modern warfighter and peacekeeper. A single unit can be re-used between 10-15 times with “recharging” (air drying) and is manufactured with greater than 50% non-hazardous bio-content.

DryRight provides the warfighter with a solution that sustains an optimum microenvironment around the foot that is critical to top performance and long-term comfort. When in use, it provides maximum boot dryness in all foot contact areas (toe, heel, top and bottom of foot) regardless of climate and weather conditions within 6-8 hours. DryRight use results in the reduction of foot blisters and damp socks. Biovation has applied its extensive expertise in advanced polymers, non-wovens, super absorbents and multi-component biochemical formulations to create a unique product.

Biovation Chief Executive Officer Kerem Durdag said, “The foot health of Marines during training and deployment is a primary medical concern for the force.  We have developed the DryRight to provide an efficient and effective tool for Marines both in combat and training. Biovation is proud to partner with Department of the Navy on this important project to protect Marines in the field.”

Biovation plans to establish a dedicated DryRight manufacturing line by April 2015, allowing orders to be taken for June 2015 delivery. Biovation is committed to the State of Maine’s high-tech innovation manufacturing economy by implementing a world-class production line and creating new high-skilled jobs to support the launch of DryRight.

About Anania & Associates Investment Company LLC

Anania & Associates Investment Company LLC (AAI) is a Maine based and focused private equity firm that partners with management teams acquiring and building companies with a high potential for growth. Founded in 2008 the fund currently has 8 portfolio companies representing over 450 employees and $75 million in revenue.  AAI is a long term, regionally focused investor focused on supporting sustainable growth for its portfolio companies which include: Biovation II LLC, Elmet Technologies LLCGrow-Tech LLCLighthouse Imaging LLC, MEGA Industries LLC, mWAVE Industries LLCSynergistic Software Solutions LLC & TrakTec LLC.

About Biovation II, LLC

Biovation is a technology design and manufacturing company that manufactures advanced non-woven fiber products with integrated antimicrobial properties for packaging, healthcare, custom advanced material OEM products, and other specialty scalable applications. Biovation has extensive experience with green biopolymers such as polylactic acid, which comes from cornstarch and is completely biodegradable. For more information, call +1.207.633.0616 or visit www.biovation.com.

 

CONTACT: David Costello: david@risingtidemhd.com; 617.875.2492

Keri Seitz Joins Biovation as VP of Sales and Customer Relations

FOR RELEASE: IMMEDIATE

February 3, 2015

Seitz will lead Biovation’s sales thrust as it launches new medical devices and products and engages with global partners

BOOTHBAY, ME – Biovation, a manufacturer of biopolymer non-woven fiber products for medical, packaging, and specialty markets, announces that Keri Seitz has joined the executive management team as Vice President of Sales and Customer Relations. Seitz brings experience in the medical device marketplace to her new role, where she is responsible for growing and managing the sales organization, providing strategic direction for Biovation’s emerging partner and distributor network, and continuing the company’s growth plans.

Keri Seitz Joins Biovation

Seitz previously served as President and CEO of FHC, a manufacturer and developer of products used in neuroscience research and neurosurgical procedures. During her tenure, the company increased revenue by almost forty percent and quadrupled net operating profit. She has extensive experience in Quality Management Systems, specifically with ISO 13485 compliance and implementation, and is knowledgeable in global medical device registration and compliance.

“I am incredibly excited that Keri has joined our team and will lead our tactical and strategic global sales efforts. During the last several years we have engaged with customers who are leaders in their market sectors, and now plan to leverage those relationships and applicable products to the larger marketplace,” says Biovation Chief Executive Officer Kerem Durdag. ”Keri is the right person to lead us in our next stage of growth given her deep experience in delivering rapid revenue growth and increasing market share through highly effective results-oriented sales practices.”

Seitz will help Biovation release several new products within this calendar year, including an infection control barrier product (the BioArmour™ Blood Pressure Cuff Shield), a specialty advanced product for the Department of Defense (the DryRight™), and several roll goods products for niche markets.

About ANANIA & Associates Investment Company LLC (AAI)

Anania & Associates Investment Company LLC, is a Maine-based private equity fund that invests in small, well-managed businesses. Founded in 2008, Anania & Associates Investment Company LLC has a strong record of sustained growth, going back to its first investment in 1996 under fund manager Anania & Associates. AAI has eight portfolio companies: Biovation LLCGrow-Tech LLCLighthouse Imaging LLCMEGA Industries LLCmWAVE Industries LLC,Synergistic Software Solutions LLC, Elmet Technologies, Inc., and TrakTec LLC.  For more information, please contact Scott Knoll, Vice President of Business Development at 207-712-1500, or visit www.Anania.biz.

About Biovation, LLC

Biovation is a technology design and manufacturing company that manufactures advanced polylactic acid (PLA)-based non-woven fiber end products and roll goods with integrated antimicrobial properties for packaging, infection control, advanced wound care, hygiene, and other specialty applications. Biovation has extensive experience with green biopolymers such as, PLA, which comes from cornstarch and is completely biodegradable. For more information, call +1.207.633.0616 or visit www.biovation.com.

CONTACT: Kerem Durdag: kdurdag@biovation.com; 207.632.2559

Press Release, June 26, 2013

Biovation announces that it has signed a $978,000 contract with US Marine Corps for a biodegradable, bioplastics boot-drying technology which incorporates super-absorbent polymer and polylactic acid (PLA) materials into a lightweight, multi-use product that quickly dries Marines’ wet boots in the field without the use of power.View full press release text »

Press Release, June 29, 2011

Biovation announces announces that its biopolymer product line has been named the New Technology Product of the Year from TechMaine, the technology association of Maine. This designation is awarded to a truly innovative, unique technology that offers a breakthrough solution to a demonstrable commercial market.View full press release text »